Ulrike Gern
- Oncology top 10%
- Molecular Biology
- Cell Biology top 10%
- Biomedical Engineering
- Immunology
- Co-authors
- Thomas SeufferleinGuido AdlerMichael SchmittAnita SchmittCarsten Müller‐TidowMaria‐Luisa SchubertLeopold SellnerPeter Dreger
- Topics
- CAR-T cell therapy research (10 papers)Virus-based gene therapy research (4 papers)Immune Cell Function and Interaction (4 papers)
- Cited by
- OncologyCell BiologyImmunology
- Partner nations
- GermanyUnited StatesBelgium
In The Last Decade
Ulrike Gern
15 papers receiving 810 citations
Peers
Comparison fields: 5 of 74
- Oncology 360
- Molecular Biology 330
- Cell Biology 184
- Biomedical Engineering 154
- Immunology 135
Countries citing papers authored by Ulrike Gern
This map shows the geographic impact of Ulrike Gern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrike Gern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrike Gern more than expected).
Fields of papers citing papers by Ulrike Gern
This network shows the impact of papers produced by Ulrike Gern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrike Gern. The network helps show where Ulrike Gern may publish in the future.
Co-authorship network of co-authors of Ulrike Gern
This figure shows the co-authorship network connecting the top 25 collaborators of Ulrike Gern. A scholar is included among the top collaborators of Ulrike Gern based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrike Gern. Ulrike Gern is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 52 | |
| 2 | 28 | |
| 3 | 15 | |
| 4 | 17 | |
| 5 | 33 | |
| 6 | 41 | |
| 7 | 42 | |
| 8 | 21 | |
| 9 | 83 | |
| 10 | 23 | |
| 11 | 218 | |
| 12 | 10 | |
| 13 | 159 | |
| 14 | 16 | |
| 15 | 59 |
About Ulrike Gern
Ulrike Gern is a scholar working on Oncology, Immunology and Genetics, having authored 15 papers that have together received 817 indexed citations. Recurring topics across this work include CAR-T cell therapy research (10 papers), Virus-based gene therapy research (4 papers) and Immune Cell Function and Interaction (4 papers). The work is most often cited by research in Oncology (360 citations), Cell Biology (184 citations) and Immunology (135 citations). Ulrike Gern has collaborated with scholars based in Germany, United States and Belgium. Frequent co-authors include Thomas Seufferlein, Guido Adler, Michael Schmitt, Anita Schmitt, Carsten Müller‐Tidow, Maria‐Luisa Schubert, Leopold Sellner, Peter Dreger, Brigitte Neuber and Lei Wang. Their work appears in journals such as Journal of Biological Chemistry, Blood and Nature Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.